AstraZeneca Plc

AstraZeneca Plc

AstraZeneca Plc

Overview
Date Founded

1992

Headquarters

Cambridge Biomedical Campus,1 Francis Crick Avenue,Cambridge, Cambridgeshire CB2 0AA

Type of Company

Public

Employees (Worldwide)

64.4K

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Data
Trying to get in touch with decision makers at AstraZeneca Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Executive Director & Chief Executive Officer

Chief Financial Officer & Executive Director

General Counsel

Executive Vice President-Sustainability, Chief Compliance Officer

Head of Research & Development, Oncology

President, BioPharmaceuticals Business Unit

Executive Vice President, Human Resources

Executive Vice President, Operations & Information Technology

Executive Vice President, Research & Development BioPharmaceuticals

Executive Vice President, International

Board of Directors

Founder at Aphrae AB

Former President & Chief Executive Officer at Investor AB

Former Chief Executive Officer & Director at Avon Products, Inc.

Chief Research Officer at Firmenich SA

Chief Financial Officer & Executive Director at AstraZeneca Plc

Chief Executive Officer at Brambles Ltd.

Former General Manager, IBM Watson Health at International Business Machines Corporation

Former Head-Genetics & Epidemiology Division at The Institute of Cancer Research

Chairman, Department of Clinical Oncology at The Chinese University of Hong Kong - Faculty of Medicine

Paths to AstraZeneca Plc
Potential Connections via
Relationship Science
You
AstraZeneca Plc
Owners & Shareholders
Details Hidden

Wellington Management's investment services rely on their extensive independent research and include portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has a number of different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macroanalysts, quantitative analysts and technical analysts. Wellington Management's portfolio management teams often include dedicated analysts who evaluate securities and other instruments for suitability based on the team's investment approach. The firm supplements their internal research with external research from sources such as broker/dealers and third-party research firms. These sources typically provide data, research and analysis and may serve as a gauge of market consensus.

Details Hidden

CWI employs a long-term, value-oriented global investment approach and a multiple portfolio manager system that combines teamwork and individual accountability. The firm is committed to maintaining low operating expenses, among the lowest in the fund industry. They utilize fundamental research to gather in-depth information on markets and companies around the world. CWI employs a security-by-security approach to portfolio construction and emphasize long-term investments. Their strategies focus on determining the difference between the fundamental value of a company and its price in the marketplace. CWI offers a wide variety of equity, fixed-income and balanced investment strategies. Their strategies are categorized as global, multi-regional and regional investment strategies.

Details Hidden

Dodge & Cox's investment decisions are made by a team of seasoned investment professionals based on key fundamental factors that they believe determine investment value over the long term. The firm's investment analysts operate from a single location to foster communication and collaboration and each investment idea is subject to committee review for both its merits as a specific investment and its role in the overall portfolio. Their approach stresses an evaluation of risk relative to opportunity and we seek investments that we believe are undervalued by the market. Fundamental bottom-up research, a rigorous valuation discipline and a long-term investment horizon are central to Dodge & Cox's investment philosophy.

Recent Transactions
Details Hidden

Novartis AG, AveXis, Inc. purchase Astrazeneca Plc /Longmont Manufacturing Operations from AstraZeneca Plc

Details Hidden

Avara Pharmaceutical Services, Inc. purchases AstraZeneca SAS /Reims facility from AstraZeneca Plc

Details Hidden

Grünenthal GmbH purchases AstraZeneca Plc /Zomig Brand from AstraZeneca Plc

Transaction Advisors
Legal Advisor

Advised onZeneca Group Plc purchases Astra AB resulting in a new company AstraZeneca Plc

Legal Advisor

Advised onAstraZeneca Plc purchases Ardea Biosciences, Inc.

Investment Advisor

Advised onAstraZeneca Plc purchases MedImmune LLC

Legal Advisor

Advised onAstraZeneca Plc purchases Ardea Biosciences, Inc.

Legal Advisor

Advised onAstraZeneca Plc purchases Almirall SA /Respiratory Drugs Business from Almirall SA

Legal Advisor

Advised onAstraZeneca Plc purchases ZS Pharma, Inc.

Advisors & Consultants
Legal Advisor

Senior Executive Vice President, General Counsel & Secretary at Comcast Corporation

Legal Advisor

Partner at Sidley Austin LLP

Legal Advisor

Partner at Davis Polk & Wardwell LLP

Clients

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Sun Pharmaceutical We are an international speciality pharma company, with a large presence in the US and India, and a footprint across 41 other markets. In the US, which is our largest market, we have built a strong pipeline of generics, directly and through our subsidiaries Caraco and Sun Pharmaceutical Inc. Taro adds strong dermatology range to this portfolio. In India and rest of the world markets, our brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, diabetology, ophthalmology, orthopedics etc. We are market leaders in speciality therapy areas in India. We retain the drive for growth that marked our early days, when we had. begun in 1983 with just 5 products. Since then, we have crossed several milestones to emerge as a leading pharma company in India where we are the 5th largest by prescription sales, a rank that we have retained over a decade. (IMS ORG Stockist Audit, March. 2012) Since the mid- nineties, we have used a combination of growth and acquisition to drive growth. important acquisitions have included those of the US, detroit-based Caraco Parma Labs and a plant at Halol which now holds UKMHRA and USFDA approvals. The 2010 acquisition of Taro Pharmaceuticals doubles our US business and brings us strengths in dermatology and pediatrics

Key Stats and Financials As of 2018
Market Capitalization
$96.4B
Total Enterprise Value
$86.2B
Earnings Per Share
$1.28
Revenue
$16.6B
Total Equity
$11B
Total Debt
$15B
Net Profit
$1.62B
EBITDAMargin
20.89%
Enterprise Value Sales
5.2x
Enterprise Value EBITDAOperating
24.9x
TEVNet Income
53.33x
Debt TEV
0.17x
EBITDA
$3.46B
Three Year Compounded Annual Growth Rate Of Revenue
0.81%
Five Year Compounded Annual Growth Rate Of Revenue
0.24%
Non-Profit Donations & Grants
$500K - $1M
2018
$5,000 +
2017
$5,000 - $10K
2016
Investments
Details Hidden

PhaseBio Pharmaceuticals, Inc. is engaged in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.

Details Hidden

Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA.

Details Hidden

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products. The firm develops a portfolio of innovative cures for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. Entasis Therapeutics Holdings was founded in March 2018 and is headquartered in Waltham, MA.

Investors
Details Hidden

Hereditary Peer at United Kingdom House of Lords

Details Hidden

Crossbencher at United Kingdom House of Lords

Details Hidden

Non-Permanent Judge at Hong Kong Court of Final Appeal

Suppliers
AptarGroup, Inc. Paper Products | Crystal Lake, IL

AptarGroup, Inc. develops, manufactures and sales of consumer product dispensing systems. It operates through the following business segments : Beauty & Home, Pharma, and Food & Beverage. The Beauty & Home segment primarily sells pumps, aerosol valves and accessories to the personal care and household markets and pumps and decorative components to the fragrance/cosmetic market. The Pharma segment supplies pumps and metered dose inhaler valves to the pharmaceutical market worldwide. The Food & Beverage segment sell dispensing and non-dispensing closures and, to a lesser degree, spray pumps and aerosol valves to the food and beverage markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Sodexo SA Other Business & Consulting Services | Issy-les-Moulineaux, IF

Sodexo SA engages in the provision of on-site services, benefits and rewards services, and personal and home care services. It offers integrated solutions which cover a variety of working and living environments and are available in client segments which include corporate, health care, education, defense, remote sites, justice services, seniors, and sports and leisure. Sodexo was founded by Pierre Bellon in 1966 and is headquartered in Issy-les-Moulineaux, France.

Alliance Data Systems Corp. Other Business & Consulting Services | Plano, Texas

Alliance Data Systems Corp. engages in the provision of data-driven and transaction-based marketing and customer loyalty solutions. It operates through the following segments: LoyaltyOne, Epsilon and Card Services. The LoyaltyOne segment provides coalition and short-term loyalty programs. The Epsilon segment offers end-to-end, integrated marketing solutions. The Card Services offers risk management solutions, account origination, funding, transaction processing, customer care, collections, and marketing services for the company's private label and co-brand credit card programs. The company was founded in 1996 and is headquartered in Columbus, Ohio.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Middlesex

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by AstraZeneca Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of AstraZeneca Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and AstraZeneca Plc.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/astrazeneca-plc-16647
  • https://relationshipscience.com/organization/astrazeneca-plc-16647